Metabolic health✎ Written by Claude — not in notes✎ Written by Claude — not in notesSection label written by Claude. Not from client notes.
Metabolic & Weight Management✓ From client notes✓ From client notesCategory name + compounds are from the client's peptide category table (provided in chat: 'Common Uses & Types of Peptide Therapy'). Factual grouping, not a claim.
The GLP-1 and GLP-1/GIP receptor agonists behind much of modern metabolic and weight-management medicine.✎ Written by Claude — not in notes✎ Written by Claude — not in notesWritten by Claude (hedged summary). Not from client notes. Replace/confirm with client copy.
Commonly discussed· Standard UI· Standard UISection label written by Claude. Not from client notes.
semaglutide, tirzepatide (GLP-1 / GIP)✓ From client notes✓ From client notesCategory name + compounds are from the client's peptide category table (provided in chat: 'Common Uses & Types of Peptide Therapy'). Factual grouping, not a claim.
The GLP-1 and GLP-1/GIP receptor agonists behind much of modern metabolic and weight-management medicine.✎ Written by Claude — not in notes✎ Written by Claude — not in notesWritten by Claude (hedged summary). Not from client notes. Replace/confirm with client copy.
Prescription therapies for weight & metabolic health✎ Written by Claude — not in notes✎ Written by Claude — not in notesWritten by Claude (hedged summary). Not from client notes. Replace/confirm with client copy.
Why it matters
Sustainable energy for daily life is the goal behind metabolic-health research.✎ Written by Claude — not in notes✎ Written by Claude — not in notesWritten by Claude. General aspirational framing tied to the research area — not a claim that any person achieved this using a specific compound.
Lifestyle photography — general mood imagery, not a patient photo or a documented result.✎ Written by Claude — not in notes✎ Written by Claude — not in notesGeneric AI-generated lifestyle/mood photography, written by Claude. This is NOT a patient, NOT a before/after, and NOT documentation of anyone's result from taking any compound — deliberately excluded per compliance guardrails (see 8015 todo list). It illustrates the research area's real-world goal, nothing more.
— The science, plainly✎ Written by Claude — not in notes✎ Written by Claude — not in notesSection heading written by Claude. Not from client notes.
What it is✎ Written by Claude — not in notes✎ Written by Claude — not in notesSection label written by Claude ('What it is' / 'What research explores' / 'Regulatory status'). Not from client notes.
Semaglutide is a GLP-1 receptor agonist; tirzepatide is a dual GLP-1/GIP receptor agonist. Both mimic gut hormones that influence blood sugar, insulin release, appetite signaling, and the rate at which the stomach empties.⌕ From research⌕ From researchWritten by Claude from web research (Aug 2026): peer-reviewed/mechanism sources on these compounds. Hedged and educational — NOT from the client notes and NOT an efficacy claim. Verify with primary literature before launch.
What research explores✎ Written by Claude — not in notes✎ Written by Claude — not in notesSection label written by Claude ('What it is' / 'What research explores' / 'Regulatory status'). Not from client notes.
These are among the most rigorously studied compounds in this space, with large randomized controlled trials supporting their approved uses in type-2 diabetes and chronic weight management under medical supervision.⌕ From research⌕ From researchWritten by Claude from web research (Aug 2026): peer-reviewed/mechanism sources on these compounds. Hedged and educational — NOT from the client notes and NOT an efficacy claim. Verify with primary literature before launch.
Regulatory status✎ Written by Claude — not in notes✎ Written by Claude — not in notesSection label written by Claude ('What it is' / 'What research explores' / 'Regulatory status'). Not from client notes.
FDA-approved prescription medications (e.g. Ozempic/Wegovy, Mounjaro/Zepbound). Available only by prescription after a licensed provider evaluates whether they're appropriate for you — never sold direct-to-consumer here.⌕ From research⌕ From researchWritten by Claude from web research (Aug 2026): peer-reviewed/mechanism sources on these compounds. Hedged and educational — NOT from the client notes and NOT an efficacy claim. Verify with primary literature before launch.
This page is general educational background, not medical advice or an offer to sell any compound. Statements here have not been evaluated by the FDA. Whether any therapy is appropriate for you is determined solely by an independent licensed provider.~ Adapted from notes~ Adapted from notesAdapted from the client's disclaimer intent (TELEGRAMNOTES.md: 'This is not FDA approved, using at your own research and you are responsible...'). Rewritten by Claude for the licensed-provider model — NOT the client's exact research-use-only wording. Needs client + legal sign-off.